DexTech Medical Investor Relations Material
Latest events
Q3 2025
29 Apr, 2025
Q2 2025
27 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from DexTech Medical
Access all reports
DexTech Medical AB is a Sweden-based medical technology company specializing in the development of diagnostic and therapeutic solutions for oncology. The company focuses on creating proprietary products for the treatment and management of cancer, with an emphasis on prostate cancer and related conditions. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Spotlight Stock Market.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
DEX
Country
🇸🇪 Sweden